Caption Management’s Vaxart VXRT Stock Holding History

Caption Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-63,700	Closed	-$320K	–	1869
2022 Q1	$320K	Buy	+63,700	New	+$323K	﹤0.01%	1204

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's VXRT Position: Q2 2022 in Review

Caption Management sold out of Vaxart (VXRT) in Q2 2022, closing a stake of 28,217 shares — an estimated $142K sold.

Caption Management first reported a position in VXRT in Q1 2021 and held it in 2 quarters. The position peaked at $142K in Q1 2022. 146 funds tracked by Wall St. Rank hold VXRT as of Q2 2022.

Caption Management reported no remaining Vaxart position as of Q2 2022 after selling out during the quarter.
Caption Management sold 28,217 Vaxart shares in Q2 2022, an estimated $142K.
Caption Management first reported a position in Vaxart in Q1 2021 and held it in 2 quarters.
Caption Management's Vaxart position peaked at $142K in Q1 2022.
146 funds tracked by Wall St. Rank held Vaxart as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.